Comorbid diagnoses for youth at clinical high risk of psychosis

被引:90
作者
Addington, Jean [1 ]
Piskulic, Danijela [1 ]
Liu, Lu [1 ]
Lockwood, Jonathan [1 ]
Cadenhead, Kristin S. [2 ]
Cannon, Tyrone D. [3 ]
Cornblatt, Barbara A. [4 ]
McGlashan, Thomas H. [5 ]
Perkins, Diana O. [6 ]
Seidman, Larry J. [7 ,8 ]
Tsuang, Ming T. [2 ,9 ]
Walker, Elaine F. [10 ]
Bearden, Carrie E. [11 ,12 ]
Mathalon, Daniel H. [13 ,14 ]
Woods, Scott W. [5 ]
机构
[1] Univ Calgary, Dept Psychiat, Hotchkiss Brain Inst, Calgary, AB, Canada
[2] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA
[3] Yale Univ, Dept Psychol, New Haven, CT USA
[4] Zucker Hillside Hosp, Dept Psychiat, Queens, NY USA
[5] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA
[6] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA
[7] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Psychiat, Boston, MA USA
[8] Massachusetts Gen Hosp, Boston, MA 02114 USA
[9] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA
[10] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA
[11] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA
[12] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA
[13] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA
[14] Psychiat Serv, San Francisco, CA USA
关键词
Clinical high risk; DSM-IV diagnoses; Comorbidity; Anxiety; Depression; ULTRA-HIGH RISK; LONGITUDINAL DATA-ANALYSIS; CANNABIS USE; PRODROME; INDIVIDUALS; TRANSITION; DISORDERS; VALIDITY; OUTCOMES; STATE;
D O I
10.1016/j.schres.2017.03.043
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Several studies have demonstrated that youth at clinical high risk (CHR) of developing psychosis have a high prevalence of comorbid psychiatric disorders. Less is known about the impact of comorbid diagnoses on later conversion to psychosis and the change over time. The aim of this study was to determine the frequency and distribution of psychiatric diagnoses at baseline and over time in the North American Prodrome Longitudinal Study (NAPLS 2) and the role of comorbid diagnoses in conversion to psychosis. The NAPLS 2 sample consisted of 744 CHR youth and 276 healthy controls. Only 21% of the CHR group did not have a comorbid diagnosis with many have 2-3 DSM-IV comorbid diagnoses. The most common diagnoses were anxiety and depressive disorders, which did improve over time. The only diagnosis at baseline that differentiated the converters from the non-converters was cannabis misuse. Comorbidity, except for cannabis use, was essentially independent of clinical outcome. It is possible that those with comorbid diagnoses are preferentially the help-seeking individuals that present for help in our clinics and research projects and that those who are at risk but do not have a comorbid diagnosis may not be seeking help in the prodromal phase. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:90 / 95
页数:6
相关论文
共 50 条
  • [41] The role of a family history of psychosis for youth at clinical high risk of psychosis
    Georgopoulos, Grace
    Stowkowy, Jacqueline
    Liu, Lu
    Cadenhead, Kristin S.
    Cannon, Tyrone D.
    Cornblatt, Barbara A.
    McGlashan, Thomas H.
    Perkins, Diana O.
    Seidman, Larry J.
    Tsuang, Ming T.
    Walker, Elaine F.
    Woods, Scott W.
    Bearden, Carrie E.
    Mathalon, Daniel H.
    Addington, Jean
    EARLY INTERVENTION IN PSYCHIATRY, 2019, 13 (02) : 251 - 256
  • [42] Prediction and Prevention of Psychosis in Youth at Clinical High Risk
    Addington, Jean
    Heinssen, Robert
    ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 8, 2012, 8 : 269 - +
  • [43] Neurocognition in Kenyan youth at clinical high risk for psychosis
    Mamah, Daniel
    Mutiso, Victoria N.
    Ndetei, David M.
    SCHIZOPHRENIA RESEARCH-COGNITION, 2021, 25
  • [44] Clinical psychopathology in youth at familial high risk for psychosis
    Shah, Jai L.
    Tandon, Neeraj
    Montrose, Debra M.
    Mermon, Diana
    Eack, Shaun M.
    Miewald, Jean
    Keshavan, Matcheri S.
    EARLY INTERVENTION IN PSYCHIATRY, 2019, 13 (02) : 297 - 303
  • [45] Environmental context predicts state fluctuations in negative symptoms in youth at clinical high risk for psychosis
    Luther, Lauren
    Raugh, Ian M.
    Collins, Delaney E.
    Berglund, Alysia
    Knippenberg, Anna R.
    Mittal, Vijay A.
    Walker, Elaine F.
    Strauss, Gregory P.
    PSYCHOLOGICAL MEDICINE, 2023, 53 (16) : 7609 - 7618
  • [46] Selective Review of Neuroimaging Findings in Youth at Clinical High Risk for Psychosis: On the Path to Biomarkers for Conversion
    Ellis, Justin K.
    Walker, Elaine F.
    Goldsmith, David R.
    FRONTIERS IN PSYCHIATRY, 2020, 11
  • [47] The relationship between childhood trauma and clinical characteristics in ultra-high risk for psychosis youth
    de Vos, Chloe
    Thompson, Andrew
    Amminger, Paul
    Bendall, Sarah
    de Haan, Lieuwe
    Hartmann, Jessica
    Lavoie, Suzie
    Markulev, Connie
    McGorry, Patrick
    Nieman, Dorien
    Phillips, Lisa
    Reininghaus, Ulrich
    Yuen, Hok Pan
    Yung, Alison
    Nelson, Barnaby
    PSYCHOSIS-PSYCHOLOGICAL SOCIAL AND INTEGRATIVE APPROACHES, 2019, 11 (01): : 28 - 41
  • [48] Clinical high risk for psychosis in children and adolescents: A meta-analysis of transition prevalences
    Raballo, Andrea
    Poletti, Michele
    Preti, Antonio
    McGorry, Patrick
    SCHIZOPHRENIA RESEARCH, 2022, 243 : 254 - 261
  • [49] Current status specifiers for patients at clinical high risk for psychosis
    Woods, Scott W.
    Walsh, Barbara C.
    Addington, Jean
    Cadenhead, Kristin S.
    Cannon, Tyrone D.
    Cornblatt, Barbara A.
    Heinssen, Robert
    Perkins, Diana O.
    Seidman, Larry J.
    Tarbox, Sarah I.
    Tsuang, Ming T.
    Walker, Elaine F.
    McGlashan, Thomas H.
    SCHIZOPHRENIA RESEARCH, 2014, 158 (1-3) : 69 - 75
  • [50] Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study
    Devoe, D. J.
    Lu, L.
    Cannon, T. D.
    Cadenhead, K. S.
    Cornblatt, B. A.
    McGlashan, T. H.
    Perkins, D. O.
    Seidman, L. J.
    Tsuang, M. T.
    Woods, S. W.
    Walker, E. F.
    Mathalon, D. H.
    Bearden, C. E.
    Addington, J.
    SCHIZOPHRENIA RESEARCH, 2021, 227 : 28 - 37